Persistence of SARS-CoV-2 antibodies in kidney transplant recipients

Ilies Benotmane; Gabriela Gautier Vargas; Aurélie Velay; Marie-José Wendling; Peggy Perrin; Samira Fafi-Kremer; Sophie Caillard

doi:10.1111/ajt.16469

Persistence of SARS-CoV-2 antibodies in kidney transplant recipients

Am J Transplant. 2021 Jun;21(6):2307-2310. doi: 10.1111/ajt.16469. Epub 2021 Jan 17.

Authors

Ilies Benotmane^{1

2

3}, Gabriela Gautier Vargas¹, Aurélie Velay^{2

3}, Marie-José Wendling³, Peggy Perrin^{1

2}, Samira Fafi-Kremer^{2

3}, Sophie Caillard^{1

2}

Affiliations

¹ Department of Nephrology and Transplantation, Strasbourg University Hospital, Strasbourg, France.
² INSERM U1109, LabEx TRANSPLANTEX, Strasbourg, France.
³ Department of Virology, Strasbourg University Hospital, Strasbourg, France.

No abstract available

Keywords: antibody biology; biomarker; clinical research/practice; immune deficiency; infection and infectious agents - viral; infectious disease; kidney transplantation/nephrology.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

COVID-19*
Humans
Immunosuppressive Agents
Kidney Transplantation*
SARS-CoV-2
Transplant Recipients

Substances

Immunosuppressive Agents

Grants and funding

7760/Strasbourg University Hospital